Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells

Area of Science:

• Environmental Health
• Cancer Biology
• Pharmacology

Background:

• Fine particulate matter (PM2.5) is a known carcinogen, significantly contributing to lung cancer development.
• PM2.5 exposure promotes tumor cell migration and invasion, exacerbating cancer progression.
• Flavonoids, like luteolin, possess antiangiogenic properties and are investigated for their potential anti-cancer effects.

Purpose of the Study:

• To investigate the efficacy of luteolin in inhibiting PM2.5-induced lung cancer progression.
• To elucidate the molecular mechanisms by which luteolin affects cancer cell migration and metastasis.
• To determine the role of the epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) signaling pathway in luteolin's anti-cancer effects.

Main Methods:

• Utilized aqueous extract of PM2.5 and H460 human lung cancer cells.
• Assessed the effects of luteolin on cell migration and invasion.
• Measured the expression levels of pro-metastatic factors, including matrix metalloproteinase-2 (MMP-2) and intercellular adhesion molecule-1 (ICAM-1).
• Investigated the involvement of the EGFR-PI3K-AKT signaling cascade.

Main Results:

• Luteolin significantly reduced cell migration in PM2.5-exposed H460 cells.
• Luteolin decreased the expression of MMP-2 and ICAM-1, key factors in metastasis.
• Luteolin treatment inhibited the PM2.5-induced activation of the EGFR-PI3K-AKT signaling pathway.
• The inhibitory effects of luteolin on MMP-2 and ICAM-1 were dependent on the EGFR-PI3K-AKT pathway.

Conclusions:

• Luteolin demonstrates potent anti-cancer properties against PM2.5-induced lung cancer progression.
• Luteolin effectively inhibits tumor cell migration and metastasis by targeting the EGFR-PI3K-AKT pathway.
• These findings highlight luteolin as a potential therapeutic agent for mitigating the adverse effects of PM2.5 exposure on lung cancer.